Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)

Autor: Brian O'Mathúna, Ricardo Pardo-Lozano, Rafael de la Torre, Elisabet Cuyàs, Clara Pérez-Mañá, Klaus Langohr, Samanta Yubero-Lahoz, Marta Torrens, Cristina Mustata, Marcel·li Carbó, Magí Farré
Přispěvatelé: Universitat Politècnica de Catalunya. Departament d'Estadística i Investigació Operativa, Universitat Politècnica de Catalunya. GREMA - Grup de Recerca en Estadística Matemàtica i les seves Aplicacions
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Male
Anatomy and Physiology
Non-Clinical Medicine
Epidemiology
Psychopharmacology
Dopamine
Ecstasy
lcsh:Medicine
Matemàtiques i estadística::Matemàtica aplicada a les ciències [Àrees temàtiques de la UPC]
Pharmacology
Cardiovascular
Toxicology
Cardiovascular System
Body Temperature
law.invention
Serotonin Agents
0302 clinical medicine
Heart Rate
law
Sex factors
lcsh:Science
Serotonin Plasma Membrane Transport Proteins
Clinical Neurophysiology
Psychiatry
Multidisciplinary
Clinical pharmacology
Adrenergic Uptake Inhibitors
Substance Abuse
Neurochemistry
MDMA
3. Good health
Mental Health
Cytochrome P-450 CYP2D6
Behavioral Pharmacology
Genetic Epidemiology
Circulatory Physiology
Medicine
Female
Citocrom P-450 -- Metabolisme
Neurochemicals
Psychology
psychological phenomena and processes
Research Article
medicine.drug
Adult
Serotonin
Drugs and Devices
medicine.medical_specialty
Biomatemàtica
N-Methyl-3
4-methylenedioxyamphetamine

Catechol O-Methyltransferase
Cardiovascular Pharmacology
Sexual and Gender Issues
Young Adult
03 medical and health sciences
Sex Factors
Diagnostic Medicine
Recreational Drug Use
mental disorders
Genetics
medicine
Humans
Pharmacokinetics
Biology
Biomathematics
Polymorphism
Genetic

Health Care Policy
Population Biology
92B Mathematical biology in general
Extramural
Network on
lcsh:R
Drug administration
Human Genetics
030227 psychiatry
MDMA (Droga)
Pharmacodynamics
Pharmacogenetics
lcsh:Q
030217 neurology & neurosurgery
Neuroscience
Zdroj: Recercat. Dipósit de la Recerca de Catalunya
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
PLoS ONE
PLoS ONE, Vol 7, Iss 10, p e47599 (2012)
Popis: The synthetic psychostimulant MDMA (±3,4-methylenedioxymethamphetamine, ecstasy) acts as an indirect serotonin, dopamine, and norepinephrine agonist and as a mechanism-based inhibitor of the cytochrome P-450 2D6 (CYP2D6). It has been suggested that women are more sensitive to MDMA effects than men but no clinical experimental studies have satisfactorily evaluated the factors contributing to such observations. There are no studies evaluating the influence of genetic polymorphism on the pharmacokinetics (CYP2D6; catechol-O-methyltransferase, COMT) and pharmacological effects of MDMA (serotonin transporter, 5-HTT; COMT). This clinical study was designed to evaluate the pharmacokinetics and physiological and subjective effects of MDMA considering gender and the genetic polymorphisms of CYP2D6, COMT, and 5-HTT. A total of 27 (12 women) healthy, recreational users of ecstasy were included (all extensive metabolizers for CYP2D6). A single oral weight-adjusted dose of MDMA was administered (1.4 mg/kg, range 75–100 mg) which was similar to recreational doses. None of the women were taking oral contraceptives and the experimental session was performed during the early follicular phase of their menstrual cycle. Principal findings show that subjects reached similar MDMA plasma concentrations, and experienced similar positive effects, irrespective of gender or CYP2D6 (not taking into consideration poor or ultra-rapid metabolizers) or COMT genotypes. However, HMMA plasma concentrations were linked to CYP2D6 genotype (higher with two functional alleles). Female subjects displayed more intense physiological (heart rate, and oral temperature) and negative effects (dizziness, sedation, depression, and psychotic symptoms). Genotypes of COMT val158met or 5-HTTLPR with high functionality (val/val or l/*) determined greater cardiovascular effects, and with low functionality (met/* or s/s) negative subjective effects (dizziness, anxiety, sedation). In conclusion, the contribution of MDMA pharmacokinetics following 1.4 mg/kg MDMA to the gender differences observed in drug effects appears to be negligible or even null. In contrast, 5-HTTLPR and COMT val158met genotypes play a major role. This study was supported by NIDA grant 5R01BA017987-01, by grants from DIUE de la Generalitat de Catalunya (2009 SGR 718), Spanish Network on Addiction Disorders grant (FIS-RTA RD06/0001/1009), and Ministerio de Educación y Ciencia grant (MICINN FI09/00355), and the support of ISCIII-FIS-CAIBERCAI08/01/0024. R. Pardo-Lozano is a recipient of a fellowship Rio Hortega (FIS CM08/00051
Databáze: OpenAIRE